Cargando…

Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products

L1 is a dizinc subclass B3 metallo-β-lactamase (MBL) that hydrolyzes most β-lactam antibiotics and is a key resistance determinant in the Gram-negative pathogen Stenotrophomonas maltophilia, an important cause of nosocomial infections in immunocompromised patients. L1 is not usefully inhibited by MB...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinchliffe, Philip, Calvopiña, Karina, Rabe, Patrick, Mojica, Maria F., Schofield, Christopher J., Dmitrienko, Gary I., Bonomo, Robert A., Vila, Alejandro J., Spencer, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148155/
https://www.ncbi.nlm.nih.gov/pubmed/36924941
http://dx.doi.org/10.1016/j.jbc.2023.104606
_version_ 1785034938540621824
author Hinchliffe, Philip
Calvopiña, Karina
Rabe, Patrick
Mojica, Maria F.
Schofield, Christopher J.
Dmitrienko, Gary I.
Bonomo, Robert A.
Vila, Alejandro J.
Spencer, James
author_facet Hinchliffe, Philip
Calvopiña, Karina
Rabe, Patrick
Mojica, Maria F.
Schofield, Christopher J.
Dmitrienko, Gary I.
Bonomo, Robert A.
Vila, Alejandro J.
Spencer, James
author_sort Hinchliffe, Philip
collection PubMed
description L1 is a dizinc subclass B3 metallo-β-lactamase (MBL) that hydrolyzes most β-lactam antibiotics and is a key resistance determinant in the Gram-negative pathogen Stenotrophomonas maltophilia, an important cause of nosocomial infections in immunocompromised patients. L1 is not usefully inhibited by MBL inhibitors in clinical trials, underlying the need for further studies on L1 structure and mechanism. We describe kinetic studies and crystal structures of L1 in complex with hydrolyzed β-lactams from the penam (mecillinam), cephem (cefoxitin/cefmetazole), and carbapenem (tebipenem, doripenem, and panipenem) classes. Despite differences in their structures, all the β-lactam-derived products hydrogen bond to Tyr33, Ser221, and Ser225 and are stabilized by interactions with a conserved hydrophobic pocket. The carbapenem products were modeled as Δ(1)-imines, with (2S)-stereochemistry. Their binding mode is determined by the presence of a 1β-methyl substituent: the Zn-bridging hydroxide either interacts with the C-6 hydroxyethyl group (1β-hydrogen-containing carbapenems) or is displaced by the C-6 carboxylate (1β-methyl-containing carbapenems). Unexpectedly, the mecillinam product is a rearranged N-formyl amide rather than penicilloic acid, with the N-formyl oxygen interacting with the Zn-bridging hydroxide. NMR studies imply mecillinam rearrangement can occur nonenzymatically in solution. Cephem-derived imine products are bound with (3R)-stereochemistry and retain their 3′ leaving groups, likely representing stable endpoints, rather than intermediates, in MBL-catalyzed hydrolysis. Our structures show preferential complex formation by carbapenem- and cephem-derived species protonated on the equivalent (β) faces and so identify interactions that stabilize diverse hydrolyzed antibiotics. These results may be exploited in developing antibiotics, and β-lactamase inhibitors, that form long-lasting complexes with dizinc MBLs.
format Online
Article
Text
id pubmed-10148155
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-101481552023-04-30 Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products Hinchliffe, Philip Calvopiña, Karina Rabe, Patrick Mojica, Maria F. Schofield, Christopher J. Dmitrienko, Gary I. Bonomo, Robert A. Vila, Alejandro J. Spencer, James J Biol Chem Research Article L1 is a dizinc subclass B3 metallo-β-lactamase (MBL) that hydrolyzes most β-lactam antibiotics and is a key resistance determinant in the Gram-negative pathogen Stenotrophomonas maltophilia, an important cause of nosocomial infections in immunocompromised patients. L1 is not usefully inhibited by MBL inhibitors in clinical trials, underlying the need for further studies on L1 structure and mechanism. We describe kinetic studies and crystal structures of L1 in complex with hydrolyzed β-lactams from the penam (mecillinam), cephem (cefoxitin/cefmetazole), and carbapenem (tebipenem, doripenem, and panipenem) classes. Despite differences in their structures, all the β-lactam-derived products hydrogen bond to Tyr33, Ser221, and Ser225 and are stabilized by interactions with a conserved hydrophobic pocket. The carbapenem products were modeled as Δ(1)-imines, with (2S)-stereochemistry. Their binding mode is determined by the presence of a 1β-methyl substituent: the Zn-bridging hydroxide either interacts with the C-6 hydroxyethyl group (1β-hydrogen-containing carbapenems) or is displaced by the C-6 carboxylate (1β-methyl-containing carbapenems). Unexpectedly, the mecillinam product is a rearranged N-formyl amide rather than penicilloic acid, with the N-formyl oxygen interacting with the Zn-bridging hydroxide. NMR studies imply mecillinam rearrangement can occur nonenzymatically in solution. Cephem-derived imine products are bound with (3R)-stereochemistry and retain their 3′ leaving groups, likely representing stable endpoints, rather than intermediates, in MBL-catalyzed hydrolysis. Our structures show preferential complex formation by carbapenem- and cephem-derived species protonated on the equivalent (β) faces and so identify interactions that stabilize diverse hydrolyzed antibiotics. These results may be exploited in developing antibiotics, and β-lactamase inhibitors, that form long-lasting complexes with dizinc MBLs. American Society for Biochemistry and Molecular Biology 2023-03-15 /pmc/articles/PMC10148155/ /pubmed/36924941 http://dx.doi.org/10.1016/j.jbc.2023.104606 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Hinchliffe, Philip
Calvopiña, Karina
Rabe, Patrick
Mojica, Maria F.
Schofield, Christopher J.
Dmitrienko, Gary I.
Bonomo, Robert A.
Vila, Alejandro J.
Spencer, James
Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products
title Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products
title_full Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products
title_fullStr Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products
title_full_unstemmed Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products
title_short Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products
title_sort interactions of hydrolyzed β-lactams with the l1 metallo-β-lactamase: crystallography supports stereoselective binding of cephem/carbapenem products
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148155/
https://www.ncbi.nlm.nih.gov/pubmed/36924941
http://dx.doi.org/10.1016/j.jbc.2023.104606
work_keys_str_mv AT hinchliffephilip interactionsofhydrolyzedblactamswiththel1metalloblactamasecrystallographysupportsstereoselectivebindingofcephemcarbapenemproducts
AT calvopinakarina interactionsofhydrolyzedblactamswiththel1metalloblactamasecrystallographysupportsstereoselectivebindingofcephemcarbapenemproducts
AT rabepatrick interactionsofhydrolyzedblactamswiththel1metalloblactamasecrystallographysupportsstereoselectivebindingofcephemcarbapenemproducts
AT mojicamariaf interactionsofhydrolyzedblactamswiththel1metalloblactamasecrystallographysupportsstereoselectivebindingofcephemcarbapenemproducts
AT schofieldchristopherj interactionsofhydrolyzedblactamswiththel1metalloblactamasecrystallographysupportsstereoselectivebindingofcephemcarbapenemproducts
AT dmitrienkogaryi interactionsofhydrolyzedblactamswiththel1metalloblactamasecrystallographysupportsstereoselectivebindingofcephemcarbapenemproducts
AT bonomoroberta interactionsofhydrolyzedblactamswiththel1metalloblactamasecrystallographysupportsstereoselectivebindingofcephemcarbapenemproducts
AT vilaalejandroj interactionsofhydrolyzedblactamswiththel1metalloblactamasecrystallographysupportsstereoselectivebindingofcephemcarbapenemproducts
AT spencerjames interactionsofhydrolyzedblactamswiththel1metalloblactamasecrystallographysupportsstereoselectivebindingofcephemcarbapenemproducts